Advertisement

Topics

Covance Inc. Strategy, SWOT and Corporate Finance Report Prices from USD $175

11:47 EST 1 Dec 2016 | BioPortfolio Reports

Summary
Covance Inc. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.



Key Findings
Detailed information on Covance Inc. required for business and competitor intelligence needs
A study of the major internal and external factors affecting Covance Inc. in the form of a SWOT analysis
An indepth view of the business model of Covance Inc. including a breakdown and examination of key business segments
Intelligence on Covance Inc.'s mergers and acquisitions MandA, strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Covance Inc., such as business expansion, restructuring, and contract wins
Large number of easytograsp charts and graphs that present important data and key trends



Reasons To Buy
Gain understanding of Covance Inc. and the factors that influence its strategies
Track strategic initiatives of the company and latest corporate news and actions
Assess Covance Inc. as a prospective partner, vendor or supplier
Support sales activities by understanding your customers' businesses better
Stay up to date on Covance Inc.'s business structure, strategy and prospects

Key Highlights
Covance Inc. Covance or "the company" is a global contract research organization and drug development services company. The company provides product development services to pharmaceutical and biotech companies. It also provides laboratory testing services to chemical, agrochemical and food industries. Covance primarily operates in the US where it is headquartered in Princeton, New Jersey and employed 12,861 people as on December 31, 2014.

Original Article: Covance Inc. Strategy, SWOT and Corporate Finance Report Prices from USD $175

NEXT ARTICLE

More From BioPortfolio on "Covance Inc. Strategy, SWOT and Corporate Finance Report Prices from USD $175"

Quick Search
Advertisement
 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...